103 related articles for article (PubMed ID: 2212539)
41. Antibacterial properties of lansoprazole alone and in combination with antimicrobial agents against Helicobacter pylori.
Nakao M
J Clin Gastroenterol; 1995; 20 Suppl 1():S32-7. PubMed ID: 7673612
[TBL] [Abstract][Full Text] [Related]
42. In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.
Coudron PE; Stratton CW
J Antimicrob Chemother; 1998 Nov; 42(5):657-60. PubMed ID: 9848452
[TBL] [Abstract][Full Text] [Related]
43. Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
Phillips K; Munster DJ; Allardyce RA; Bagshaw PF
J Clin Pathol; 1993 Apr; 46(4):372-3. PubMed ID: 8496397
[TBL] [Abstract][Full Text] [Related]
44. [The resistance of Helicobacter pylori toward metronidazole and clarithromycin].
Zheng X; Hu F; Wang W
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1211-3. PubMed ID: 11769712
[No Abstract] [Full Text] [Related]
45. Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones.
Sánchez JE; Sáenz NG; Rincón MR; Martín IT; Sánchez EG; Martínez MJ
J Antimicrob Chemother; 2000 Aug; 46(2):283-5. PubMed ID: 10933654
[TBL] [Abstract][Full Text] [Related]
46. [In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
González C; García A; Daroch F; Kawaguchi F; Solar H; Rivera N; Vega E
Rev Med Chil; 2001 Jun; 129(6):643-6. PubMed ID: 11510204
[TBL] [Abstract][Full Text] [Related]
47. Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
Brenciaglia MI; Fornara AM; Scaltrito MM; Braga PC; Dubini F
J Chemother; 1996 Feb; 8(1):52-4. PubMed ID: 8835109
[TBL] [Abstract][Full Text] [Related]
48. Prevalence of primary Helicobacter pylori resistance to several antimicrobials in a Saudi Teaching Hospital.
Eltahawy AT
Med Princ Pract; 2002; 11(2):65-8. PubMed ID: 12123105
[TBL] [Abstract][Full Text] [Related]
49. [Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Sugita K; Katouno Y; Uchida H; Kobayashi Y
Jpn J Antibiot; 2002 Dec; 55(6):771-7. PubMed ID: 12621731
[TBL] [Abstract][Full Text] [Related]
50. [Antibacterial activity of 16 antibiotics against Helicobacter pylori].
Hosaka Y; Irinoda K; Nakano R; Kitasato H; Okamoto R; Saigenji K; Inoue M
Jpn J Antibiot; 2000 Oct; 53(10):623-30. PubMed ID: 11190047
[TBL] [Abstract][Full Text] [Related]
51. Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin.
Baffone W; Pianetti A; Citterio B; Lombardelli G; Vittoria E; Bruscolini F
J Chemother; 2001 Apr; 13(2):126-32. PubMed ID: 11330358
[TBL] [Abstract][Full Text] [Related]
52. Helicobacter pylori primary resistant strains over 11 years in French children.
Kalach N; Serhal L; Asmar E; Campeotto F; Bergeret M; Dehecq E; Spyckerelle C; Charkaluk ML; Decoster A; Dupont C; Raymond J
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):217-22. PubMed ID: 17662555
[TBL] [Abstract][Full Text] [Related]
53. [Susceptibility of Campylobacter pyloridis to antibiotics].
Freland C; Massoubre B; Drugeon HB
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):809-12. PubMed ID: 3309819
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
Debets-Ossenkopp YJ; Herscheid AJ; Pot RG; Kuipers EJ; Kusters JG; Vandenbroucke-Grauls CM
J Antimicrob Chemother; 1999 Apr; 43(4):511-5. PubMed ID: 10350380
[TBL] [Abstract][Full Text] [Related]
55. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.
Megraud F; Coenen S; Versporten A; Kist M; Lopez-Brea M; Hirschl AM; Andersen LP; Goossens H; Glupczynski Y;
Gut; 2013 Jan; 62(1):34-42. PubMed ID: 22580412
[TBL] [Abstract][Full Text] [Related]
56. Antibiotic susceptibility of Helicobacter pylori in Iceland.
Gunnarsdottir AI; Gudjonsson H; Hardardottir H; Jonsdottir KD; Bjornsson ES
Infect Dis (Lond); 2017 Sep; 49(9):647-654. PubMed ID: 28440099
[TBL] [Abstract][Full Text] [Related]
57. In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Di Giulio M; Di Campli E; Di Bartolomeo S; Cataldi V; Marzio L; Grossi L; Ciccaglione AF; Nostro A; Cellini L
Scand J Gastroenterol; 2016 Mar; 51(3):263-9. PubMed ID: 26554617
[TBL] [Abstract][Full Text] [Related]
58. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide.
Piotrowski J; Murty VL; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1995 Mar; 35(3):467-72. PubMed ID: 7773183
[TBL] [Abstract][Full Text] [Related]
59. Kill kinetics of antimicrobial agents against Helicobacter pylori.
Flamm RK; Beyer J; Tanaka SK; Clement J
J Antimicrob Chemother; 1996 Oct; 38(4):719-25. PubMed ID: 8937967
[TBL] [Abstract][Full Text] [Related]
60. Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
Malizia T; Tejada M; Marchetti F; Favini P; Pizzarelli G; Campa M; Senesi S
J Antimicrob Chemother; 1998 Mar; 41 Suppl B():29-35. PubMed ID: 9579710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
